NCT06668519
Recruiting
N/A
An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Epilepsy
- Sponsor
- Children's Hospital of Fudan University
- Enrollment
- 1500
- Locations
- 1
- Primary Endpoint
- Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.
Detailed Description
The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders
Investigators
Eligibility Criteria
Inclusion Criteria
- •aged 1 month-18 years old (date of investigate minus date of birth)
- •intracranial tumors
- •cerebrovascular diseases
- •mental retardation
- •tic disorder
- •neuropsychiatric disorders
Exclusion Criteria
- •1.Unable to cooperate with the exam of MEG
Outcomes
Primary Outcomes
Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children
Time Frame: 3 years
Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria
Study Sites (1)
Loading locations...
Similar Trials
Unknown
N/A
The Performance of the Mologic Biomarker Panel in InfectionSepsisInfectionNCT03217552Mologic Ltd600
Completed
N/A
The Vertos MILD™ Preliminary Patient Evaluation StudyLumbar Spinal StenosisNCT00749073Vertos Medical, Inc.10
Terminated
N/A
OLIF25™ /OLIF51™ StudyDegenerative Disc DiseaseScoliosisNCT02657421Medtronic Spinal and Biologics168
Recruiting
N/A
Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain MetastasesNon-small Cell Lung Cancer MetastaticBrain MetastasesNCT05638425Xiangya Hospital of Central South University20
Unknown
Early Phase 1
Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell LymphomaRefractory B-Cell LymphomaNCT03824951Allife Medical Science and Technology Co., Ltd.10